Abbott Lab's MitraClip is in the news today, based on it's new research presented at the American College of Cardiology. The reserach shows that the device, which is approved for use in Europe, may be safer than surgery, and nearly as effective (87.8% success rate over course of a year, compared with a 72.4% success rate).

The news is big for the company and should help pave the way for the device's acceptance into other markets. Various reporters took different tacts to talk about the device. Here are a couple of ways the story was presented: 

The Daily News took the celebrity approach, reporting that Elizabeth Taylor told her Twitter followers that she received the Mitraclip in October 2009. According to the paper, Taylor told fans that "It's very new and involves repairing my leaky valve using a clip device, without open heart surgery," she wrote, asking for "any prayers you happen to have lying around."Later, she tweeted: "My heart procedure went off perfectly. It's like having a brand new ticker."

Lisa LaMotte of Minyanville reports that medical devices are the new black at this year’s annual meeting of the American College of Cardiology. She says that Abbott expects the MitraClip to be approved in 2011 and believes it could eventually garner a market of almost $1 billion. LaMotte said that products like catheters and stents have usurped heart drugs that usually take center stage at the four-day meeting. She said it proves that "devices could be the next big growth drivers for a realm of companies."